SARS-CoV-2 Antigen Schnelltest (BfArM Test-ID: AT111/20), Evaluiert durch das Paul-Ehrlich-Institut (PEI), Abgesetzt

Catalog No : IGXGB-20
137.00€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name SARS-CoV-2 Antigen Schnelltest (BfArM Test-ID: AT111/20), Evaluiert durch das Paul-Ehrlich-Institut (PEI), Abgesetzt
Catalog No IGXGB-20
Supplier’s Catalog No IGXGB-20
Supplier Genrui Biotech
Source antigen SARS-CoV2
Reactivity SARS-CoV-2 and SARS-CoV-2 variants: B.1.1.7, D614G, VOC-202012/01, 501.Y.V1, 501Y.V2
Cross reactivity SARS-CoV-2 nucleocapsid protein has sequence homology with SARS-CoV therefore cross-reactivity cannot be ruled out.
Applications Qualtitative detection
Molecular weight N/A
Storage Room Temperature 2-30°C
Other names COVID-19 Antigen Rapid Test Kit, SARS-CoV-2, COVID19, nCoV, Novel Corona virus, 2019-nCoV, SARS-CoV2, COVID-19, SARS-CoV-2 antigen test, COVID-19 Antigen Test Kit, Alternative to Joysbio IGXJS-01, COVID-19 Antigen Schnelltest, COVID19 Antigen Schnelltest, SARS-CoV-2 Antigen Schnelltest, COVID-19 Ag
Grade Molecular diagnostic grade
Purity -
Form Sealed Kit+Liquid
Reactivity life The test is stable until the expiration date printed on the sealed pouch.
Note For Professional In Vitro diagnostics
Description This kit is used for the qualitative detection of the COVID-19 Antigen in Nasal (1.5-2.5cm) or Nasopharyngeal swab. Clinical trials of COVID-19 Antigen Rapid Test Kit were conducted in Shenzhen Center for Disease Control and Prevention (Shenzhen CDC), Wuhan Pulmonary Hospital (Wuhan Institute for Tuberculosis Control) and Guangdong Customs. Testing was performed from May to September 2020. A total of 181 positive specimens and 205 negative specimens were tested with this COVID-19 Antigen Rapid Test Kit. Sensitivity: 95.03% (95%-CI*: 90.77%~97.70%) Specificity: 99.02% (95%-CI*: 96.52%~98.57%). The Limit of Detection (LoD) of this kit is 1.8x10^2 TCID50/mL, calculated through a gradient dilution method. This kit is only provided for use by clinical laboratories, doctors or to healthcare workers for point-of-care testing, not for at-home testing.